Open AccessTaxol extravasation: A case report
Author(s) -
Wendy Bailey,
R. Michael Crump
Publication year - 1997
Publication title -
canadian oncology nursing journal
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2368-8076
pISSN - 1181-912X
DOI - 10.5737/1181912x729697
Subject(s) - extravasation , intervention (counseling) , medicine , drug , pharmacology , intensive care medicine , pathology , psychiatry
Taxol is a relatively new antineoplastic agent whose classification as either vesicant, non-vesicant, or irritant remains under debate. This case study is presented to follow a large-volume Taxol extravasation. The article illustrates assessment, follow-up, intervention and outcome of this situation. This case suggests the drug is a vesicant with the potential to cause moderate soft tissue injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom